📰 Mobile Android News
Page 6 - Mobile Android News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mobile Android. Real-time updates on events, politics, business and more.
June 28, 2022
Following the Supreme Court's decision on Dobbs v. Jackson Women’s Health Organization, HHS Secretary Xavier Becerra announced the department’s plans for enabling access to reproductive health care at a press conference.
June 28, 2022
Botaretigene sparoparvovec, an investigational gene therapy, was safe and improved vision in subjects with X-linked retinitis pigmentosa with disease-causing variants in the RPGR gene, according to a press release from MeiraGTx.
June 27, 2022
Older adults with type 1 diabetes initiating continuous glucose monitoring for the first time had a reduction in time spent in hypoglycemia, improved time in range and a lower HbA1c, according to findings from a randomized clinical trial. In the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) study, adults aged 60 years and older with type 1 diabetes randomly assigned to CGM had
June 27, 2022
LONDON — Exposure to proton pump inhibitors correlated with an increased risk for severe infection and cirrhosis decompensation among a subset of patients with cirrhosis, according to research presented at the International Liver Congress. “The safety of PPIs in cirrhosis remains quite controversial,” Nadim Mahmud, MD, MS, MPH, MSCE, assistant professor of medicine and
June 27, 2022
PHILADELPHIA — In this Healio video exclusive, Joshua J. Joseph, MD, MPH, FAHA, discussed the recent American Heart Association scientific statement on health equity in managing CV risk in type 2 diabetes.As Healio previously reported, the scientific statement, published in Circulation, is based on an extensive review of clinical trial results through June 2020 and addresses the managing of
June 27, 2022
The FDA approved lisocabtagene maraleucel for treatment of adults with relapsed or refractory large B-cell lymphoma after one prior therapy.
June 27, 2022
Molecular signature response classifier-assisted rheumatoid arthritis treatment selection may improve real-world results in patients with rheumatoid arthritis, according to data published in Expert Opinion on Biological Therapy. “This study reports the second interim analysis of the [Accelerate Information of Molecular Signatures (AIMS)] real-world study evaluating the clinical utility of
June 26, 2022
The FDA granted fast track designation to PDS0101 for treatment of certain patients with head and neck cancer.The designation applies to use of the agent in combination with pembrolizumab (Keytruda, Merck) by patients with recurrent or metastatic HPV16-positive disease.
June 25, 2022
LONDON — Patients with nonalcoholic fatty liver disease had worse health-related quality of life, regardless of fibrosis stage, compared with the general population, according to research presented at the International Liver Congress. “Health-related quality of life has been shown to be impaired in NAFLD patients and potentially associated with fibrosis severity, obesity or other
June 24, 2022
LONDON — The Gender-Equity Model for Liver Allocation and its sodium-corrected variant were better predictors of mortality or delisting in patients awaiting liver transplantation and may correct gender disparities, according to research. “The odds of delisting for sickness in women are 30% higher than in men, and this may have something to do with serum creatinine,” Manuel